Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1)
Xiang‐Yang Ye(Hangzhou Normal University), Jeffrey A. Robl(Bristol-Myers Squibb (Germany)), Rajasree Golla(Bristol-Myers Squibb (United States)), Akbar Nayeem(Bristol-Myers Squibb (United States)), Bogdan Sleczka(Bristol-Myers Squibb (United States)), Bin He(Guiyang Medical University), Mengmeng Wang(Bristol-Myers Squibb (United States)), Yixin Li(Bristol-Myers Squibb (United States)), Stephanie Chen(Cochlear (Australia)), David A. Gordon(Bristol-Myers Squibb (United States)), Timothy W. Harper(Bristol-Myers Squibb (United States)), Mark Kirby(Bristol-Myers Squibb (United States)), Ramakrishna Seethala(Bristol-Myers Squibb (United States))
Cited by 12
Related Papers
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
|Nature|2007|732
Overview of lethal human coronaviruses
|Signal Transduction and Targeted Therapy|2020|312
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
|Acta Neuropathologica Communications|2017|306